Molecule,Brand Examples,Jurisdiction,Core Expiry,Possible Extensions,Notes
Semaglutide,"Ozempic, Wegovy, Rybelsus","Brazil, India, Canada, China, Turkey",2026,,First expiries in emerging markets
Semaglutide,"Ozempic, Wegovy, Rybelsus",U.S.,2032,2039,Supplementary patents may extend to 2039
Semaglutide,"Ozempic, Wegovy, Rybelsus",Europe/Japan,2031,,Composition patent expiries
Tirzepatide,"Mounjaro, Zepbound",U.S.,2036,2039â€“2041,"Core compound patent (US 9,474,780); device/formulation add-ons"
